Last reviewed · How we verify

NCT04157946: MPARDS

The Role of Morphological Phenotype in ARDS

Completed Last updated 8 November 2019
What this trial tests

trial testing CT in Respiratory Distress Syndrome, Adult in 12 participants. Completed in 20 July 2019.

Timeline
7 August 2017
Primary endpoint
10 July 2019
20 July 2019

Quick facts

Lead sponsorHospital El Cruce
StatusCompleted
Study typeOBSERVATIONAL
Enrollment12
Start date7 August 2017
Primary completion10 July 2019
Estimated completion20 July 2019
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

Hospital El Cruce

Who can join

18 and older, any sex, with Respiratory Distress Syndrome, Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although most of the information focuses on understanding how the ventilator produces lung damage, the pulmonary factors that predispose to ventilator-induced lung injury (VILI) have been less studied. Acute respiratory distress syndrome (ARDS) can adopt different morphological phenotypes, with its own clinical and mechanical characteristics. This morphological phenotypes may favor the development of VILI for same ventilatory strategy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Highlights from the Respiratory Failure and Mechanical Ventilation Conference 2024.
    Bianquis C, De Leo G, Morana G, Duarte-Silva M, et al · · 2024 · PMID 39534488 · DOI 10.1183/20734735.0105-2024

Verify or expand the search:

Other trials of CT

Trials testing the same drug.

Other recruiting trials for Respiratory Distress Syndrome, Adult

Currently open trials in the same condition.

Other Hospital El Cruce trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04157946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing